Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KTTA - Pasithea Therapeutics Corp


Previous close
4.7104
0   0%

Share volume: 942
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$4.71
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
14%
Profitability 6%
Dept financing 2%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-2.12%
1 Month
-11.28%
3 Months
-22.20%
6 Months
-40.12%
1 Year
-62.75%
2 Year
-80.55%
Key data
Stock price
$4.71
P/E Ratio 
-0.30
DAY RANGE
N/A - N/A
EPS 
-$0.61
52 WEEK RANGE
$4.40 - $17.40
52 WEEK CHANGE
-$0.63
MARKET CAP 
4.752 M
YIELD 
N/A
SHARES OUTSTANDING 
1.044 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$15,489
AVERAGE 30 VOLUME 
$25,614
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news